CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: quinoxaline
Accession: CHEBI:36616
browse the term
Definition: A naphthyridine in which the nitrogens are at positions 1 and 4.
Synonyms: related_synonym: 1,4-benzodiazine; 1,4-diazanaphthalene; 1,4-naphthyridine; Chinoxalin; Formula=C8H6N2; InChI=1S/C8H6N2/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6H; InChIKey=XSCHRSMBECNVNS-UHFFFAOYSA-N; SMILES=c1ccc2nccnc2c1; benzo[a]pyrazine; benzoparadiazine; benzopyrazine
xref: CAS:91-19-0; Gmelin:82755; KEGG:C18575; PMID:16406213; PMID:24328679; PMID:24476762; PMID:27349448; Reaxys:109351; Wikipedia:Quinoxaline
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased expression of BAX mRNA
CTD
PMID:23810796
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of BCL2 mRNA; 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of BCL2 protein
CTD
PMID:23810796
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CDKN1A mRNA; 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CDKN1A protein
CTD
PMID:23810796
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
affects activity increases expression
ISO
CYP1A1 affects the activity of 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CYP1A1 mRNA
CTD
PMID:2334931 PMID:23810796
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression increases activity multiple interactions
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CYP1A2 mRNA CYP1A2 results in increased activity of 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine
CTD
PMID:2334931 PMID:23810796 PMID:28160022
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Eps8l3
EPS8 signaling adaptor L3
affects response to substance
ISO
EPS8L3 protein affects the susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine
CTD
PMID:19223546
NCBI chr 2:198,202,862...198,216,255
Ensembl chr 2:195,514,692...195,528,085
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of GADD45A mRNA
CTD
PMID:23810796
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gsta1
glutathione S-transferase alpha 1
decreases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased expression of GSTA1 mRNA
CTD
PMID:23810796
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:23,703,477...23,720,121
G
H2ax
H2A.X variant histone
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of H2AX protein modified form
CTD
PMID:28160022
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of MDM2 mRNA
CTD
PMID:23810796
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Nat2
N-acetyltransferase 2
multiple interactions
ISO
NAT2 protein results in increased metabolism of and results in increased susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine
CTD
PMID:28160022
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:22,208,194...22,238,520
G
Slc22a1
solute carrier family 22 member 1
multiple interactions decreases activity
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine inhibits the reaction [SLC22A1 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased activity of SLC22A1 protein
CTD
PMID:30189235
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
decreases activity multiple interactions
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased activity of SLC22A2 protein 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a3
solute carrier family 22 member 3
decreases activity multiple interactions
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased activity of SLC22A3 protein 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:48,235,476...48,324,612
G
Tp53
tumor protein p53
increases expression decreases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of TP53 protein 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased expression of TP53 mRNA
CTD
PMID:23810796
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of UGT1A1 mRNA
CTD
PMID:23810796
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]
CTD
PMID:25896968
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:25896968
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:25896968
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Pdgfb
platelet derived growth factor subunit B
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFB mRNA]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased secretion of PDGFB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline results in decreased susceptibility to [PDGFB protein binds to PDGFB protein]
CTD
PMID:16149045 PMID:23457620 PMID:25896968
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfrb
platelet derived growth factor receptor beta
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]
CTD
PMID:16149045 PMID:25896968
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Aco2
aconitase 2
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Kainic Acid results in decreased activity of ACO2 protein]
CTD
PMID:11520895
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:113,385,646...113,428,261
G
Bdnf
brain-derived neurotrophic factor
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA alternative form]
CTD
PMID:15183516
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Casp3
caspase 3
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]]
CTD
PMID:24995437
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased expression of FOS]
CTD
PMID:10401552
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gfap
glial fibrillary acidic protein
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein]
CTD
PMID:21863293
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
multiple interactions increases expression
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA1 protein CNQX increases expression of Gria1 protein in nucleus accumbens cultured cells CNQX inhibits the reaction [Glutamate increases localization of Gria1 protein within medium spiny neurons]
CTD RGD
PMID:19674091 PMID:19674091 PMID:15255976
RGD:4107725 , RGD:405820209
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
multiple interactions increases expression
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA2 protein CNQX increases expression of Gria1 protein in nucleus accumbens cultured cells
CTD RGD
PMID:19674091 PMID:19674091
RGD:4107725
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]
CTD
PMID:15385614 PMID:19850060
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein] 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]
CTD
PMID:15385614 PMID:19850060
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Nefl
neurofilament light chain
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [N-Methylaspartate results in decreased expression of NEFL mRNA]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA]
CTD
PMID:21863293 PMID:31969611
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFM protein]
CTD
PMID:21863293
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:42,360,454...42,365,755
G
Sct
secretin
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [SCT protein results in increased secretion of gamma-Aminobutyric Acid]
CTD
PMID:15963647
NCBI chr 1:205,812,435...205,813,246
Ensembl chr 1:196,382,856...196,383,658
G
Tac1
tachykinin, precursor 1
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [L 703606 results in increased activity of TAC1 protein]
CTD
PMID:14985054
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:35,679,704...35,687,178
G
Vim
vimentin
multiple interactions
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein]
CTD
PMID:21863293
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Adra2a
adrenoceptor alpha 2A
multiple interactions
ISO EXP
Brimonidine Tartrate inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein]; Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]; Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]]; Yohimbine inhibits the reaction [Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]]
CTD
PMID:8397342 PMID:10742289 PMID:12208771 PMID:12598592
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:253,060,218...253,064,365
G
Agt
angiotensinogen
multiple interactions
EXP
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]
CTD
PMID:18250367
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Cftr
CF transmembrane conductance regulator
multiple interactions
ISO
Brimonidine Tartrate inhibits the reaction [CFTR protein affects the transport of Chlorides]
CTD
PMID:12598592
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:46,560,885...46,728,756
G
Creb1
cAMP responsive element binding protein 1
increases phosphorylation
EXP
Brimonidine Tartrate results in increased phosphorylation of CREB1 protein
CTD
PMID:17680988
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Prkca
protein kinase C, alpha
affects localization multiple interactions
EXP
Brimonidine Tartrate affects the localization of PRKCA protein Nitric Oxide deficiency promotes the reaction [Brimonidine Tartrate affects the localization of PRKCA protein]
CTD
PMID:12388232
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
G
Prkcd
protein kinase C, delta
affects localization multiple interactions
EXP
Brimonidine Tartrate affects the localization of PRKCD protein Nitric Oxide deficiency inhibits the reaction [Brimonidine Tartrate affects the localization of PRKCD protein]
CTD
PMID:12388232
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,769,215...5,799,352
G
Rhoa
ras homolog family member A
multiple interactions
EXP
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]
CTD
PMID:18250367
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Brimonidine Tartrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
EXP
Carbadox results in increased expression of CDKN1A mRNA; Carbadox results in increased expression of CDKN1A protein
CTD
PMID:26558467
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Mdm2
MDM2 proto-oncogene
increases expression
EXP
Carbadox results in increased expression of MDM2 mRNA
CTD
PMID:26558467
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Mki67
marker of proliferation Ki-67
decreases expression
EXP
Carbadox results in decreased expression of MKI67 protein
CTD
PMID:26558467
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Top2a
DNA topoisomerase II alpha
decreases expression
EXP
Carbadox results in decreased expression of TOP2A protein
CTD
PMID:26558467
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874
G
Car9
carbonic anhydrase 9
multiple interactions
ISO
CAY10591 inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]
CTD
PMID:34520103
NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:57,763,206...57,769,838
G
Sirt1
sirtuin 1
increases activity
ISO
CAY10591 results in increased activity of SIRT1 protein
CTD
PMID:34520103
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Adra1b
adrenoceptor alpha 1B
multiple interactions
EXP
cyclazosin binds to and results in decreased activity of ADRA1B protein
CTD
PMID:15951348
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,255,025...28,312,919
G
Ache
acetylcholinesterase
decreases activity multiple interactions
EXP ISO
quinalphos results in decreased activity of ACHE protein quinalphos metabolite results in decreased activity of ACHE protein; quinalphos results in decreased activity of ACHE protein Arsenic promotes the reaction [quinalphos results in decreased activity of ACHE protein]; quinalphos promotes the reaction [Arsenic results in decreased activity of ACHE protein]
CTD
PMID:32270456 PMID:33844597
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
quinalphos binds to and results in increased activity of AHR protein
CTD
PMID:18835618
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Alb
albumin
multiple interactions
EXP
[Arsenic co-treated with quinalphos] results in decreased expression of ALB protein
CTD
PMID:32270456
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Ar
androgen receptor
multiple interactions
ISO
Dihydrotestosterone inhibits the reaction [quinalphos results in increased activity of AR protein]
CTD
PMID:15064155
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Bche
butyrylcholinesterase
decreases activity multiple interactions
ISO
quinalphos results in decreased activity of BCHE protein pralidoxime inhibits the reaction [quinalphos results in decreased activity of BCHE protein]
CTD
PMID:24052565
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Cat
catalase
multiple interactions decreases activity
ISO EXP
Plant Extracts inhibits the reaction [quinalphos results in decreased activity of CAT protein] [Arsenic co-treated with quinalphos] results in decreased activity of CAT protein
CTD
PMID:24581381 PMID:32270456
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
increases expression
ISO
quinalphos results in increased expression of CYP19A1 mRNA
CTD
PMID:34014595
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
decreases expression multiple interactions
ISO
quinalphos results in decreased expression of CYP26B1 mRNA Plant Extracts inhibits the reaction [quinalphos results in decreased expression of CYP26B1 mRNA]
CTD
PMID:24581381
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:117,041,808...117,058,628
G
Esr1
estrogen receptor 1
increases activity
ISO
quinalphos results in increased activity of ESR1 protein
CTD
PMID:15064155
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
increases activity
ISO
quinalphos results in increased activity of ESR2 protein
CTD
PMID:15064155
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions affects activity
EXP
[Monocrotophos co-treated with quinalphos] affects the activity of G6PD protein quinalphos affects the activity of G6PD protein
CTD
PMID:24248738
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gsr
glutathione-disulfide reductase
multiple interactions decreases activity affects activity
EXP
[Arsenic co-treated with quinalphos] results in decreased activity of GSR protein; [Monocrotophos co-treated with quinalphos] affects the activity of GSR protein quinalphos results in decreased activity of GSR protein quinalphos affects the activity of GSR protein
CTD
PMID:24248738 PMID:32270456
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Hsd3b3
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3
multiple interactions decreases expression
ISO
Plant Extracts inhibits the reaction [quinalphos results in decreased expression of HSD3B3 mRNA]
CTD
PMID:24581381
NCBI chr 2:188,826,756...188,832,734
Ensembl chr 2:186,138,044...186,144,033
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
quinalphos binds to and results in increased activity of NR1I2 protein
CTD
PMID:21115097
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
G
Star
steroidogenic acute regulatory protein
multiple interactions decreases expression
ISO
Plant Extracts inhibits the reaction [quinalphos results in decreased expression of STAR mRNA]; Plant Extracts inhibits the reaction [quinalphos results in decreased expression of STAR protein] quinalphos results in decreased expression of STAR mRNA; quinalphos results in decreased expression of STAR protein
CTD
PMID:24581381
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672
G
Tp53
tumor protein p53
affects activity
ISO
quinalphos metabolite affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression affects expression
ISO
quinomethionate results in increased expression of AKR1C1 mRNA quinomethionate affects the expression of AKR1C1 mRNA
CTD
PMID:15387888 PMID:18214805
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Btg2
BTG anti-proliferation factor 2
affects expression
ISO
quinomethionate affects the expression of BTG2 mRNA
CTD
PMID:15387888
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:45,531,925...45,535,628
G
Cebpd
CCAAT/enhancer binding protein delta
affects expression
ISO
quinomethionate affects the expression of CEBPD mRNA
CTD
PMID:15387888
NCBI chr11:98,268,856...98,269,994
Ensembl chr11:84,764,565...84,765,829
G
Cxcl2
C-X-C motif chemokine ligand 2
affects expression
ISO
quinomethionate affects the expression of CXCL2 mRNA
CTD
PMID:15387888
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
affects expression increases expression
ISO
quinomethionate affects the expression of CYP2A13 mRNA quinomethionate results in increased expression of CYP2A13 mRNA
CTD
PMID:15387888 PMID:18214805
NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:82,231,611...82,244,887
G
Etv4
ETS variant transcription factor 4
affects expression
ISO
quinomethionate affects the expression of ETV4 mRNA
CTD
PMID:15387888
NCBI chr10:87,206,977...87,222,202
Ensembl chr10:86,706,749...86,721,974
G
Ewsr1
EWS RNA-binding protein 1
affects expression
ISO
quinomethionate affects the expression of EWSR1 mRNA
CTD
PMID:15387888
NCBI chr14:84,179,413...84,208,149
Ensembl chr14:79,965,368...79,994,544
G
Fkbp5
FKBP prolyl isomerase 5
affects expression
ISO
quinomethionate affects the expression of FKBP5 mRNA
CTD
PMID:15387888
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
affects expression
ISO
quinomethionate affects the expression of FOS mRNA
CTD
PMID:15387888
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
affects expression
ISO
quinomethionate affects the expression of GADD45A mRNA
CTD
PMID:15387888
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Hnrnpf
heterogeneous nuclear ribonucleoprotein F
affects expression
ISO
quinomethionate affects the expression of HNRNPF mRNA
CTD
PMID:15387888
NCBI chr 4:152,755,668...152,776,867
Ensembl chr 4:151,083,062...151,109,038
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
affects expression
ISO
quinomethionate affects the expression of JUNB mRNA
CTD
PMID:15387888
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
affects expression
ISO
quinomethionate affects the expression of JUND mRNA
CTD
PMID:15387888
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799
G
Lmnb1
lamin B1
affects expression
ISO
quinomethionate affects the expression of LMNB1 mRNA
CTD
PMID:15387888
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:50,175,874...50,214,502
G
Map2k1
mitogen activated protein kinase kinase 1
affects expression
ISO
quinomethionate affects the expression of MAP2K1 mRNA
CTD
PMID:15387888
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Mat2a
methionine adenosyltransferase 2A
affects expression
ISO
quinomethionate affects the expression of MAT2A mRNA
CTD
PMID:15387888
NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:104,488,466...104,495,493
G
Nfkbia
NFKB inhibitor alpha
affects expression
ISO
quinomethionate affects the expression of NFKBIA mRNA
CTD
PMID:15387888
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Phb1
prohibitin 1
affects expression
ISO
quinomethionate affects the expression of PHB1 mRNA
CTD
PMID:15387888
NCBI chr10:81,102,043...81,114,815
Ensembl chr10:80,605,251...80,618,042
G
Ppib
peptidylprolyl isomerase B
affects expression
ISO
quinomethionate affects the expression of PPIB mRNA
CTD
PMID:15387888
NCBI chr 8:75,498,966...75,504,823
Ensembl chr 8:66,603,861...66,630,428
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
affects expression
ISO
quinomethionate affects the expression of RAF1 mRNA
CTD
PMID:15387888
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
G
Rarg
retinoic acid receptor, gamma
affects expression
ISO
quinomethionate affects the expression of RARG mRNA
CTD
PMID:15387888
NCBI chr 7:135,246,427...135,268,889
Ensembl chr 7:133,367,833...133,390,177
G
Rbm39
RNA binding motif protein 39
affects expression
ISO
quinomethionate affects the expression of RBM39 mRNA
CTD
PMID:15387888
NCBI chr 3:144,662,998...144,696,222
Ensembl chr 3:144,663,001...144,696,213
G
Rnd3
Rho family GTPase 3
affects expression
ISO
quinomethionate affects the expression of RND3 mRNA
CTD
PMID:15387888
NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:35,571,143...35,589,327
G
Sumo1
small ubiquitin-like modifier 1
affects expression
ISO
quinomethionate affects the expression of SUMO1 mRNA
CTD
PMID:15387888
NCBI chr 9:68,572,901...68,602,803
Ensembl chr 9:61,077,435...61,108,761
G
Tgfa
transforming growth factor alpha
affects expression
ISO
quinomethionate affects the expression of TGFA mRNA
CTD
PMID:15387888
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:118,618,269...118,700,894
G
Uqcrc2
ubiquinol cytochrome c reductase core protein 2
affects expression
ISO
quinomethionate affects the expression of UQCRC2 mRNA
CTD
PMID:15387888
NCBI chr 1:184,599,240...184,629,804
Ensembl chr 1:175,167,894...175,199,453
G
Vegfa
vascular endothelial growth factor A
affects expression
ISO
quinomethionate affects the expression of VEGFA mRNA
CTD
PMID:15387888
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Acox1
acyl-CoA oxidase 1
increases activity increases expression multiple interactions
EXP
quizalofop-ethyl analog results in increased activity of ACOX1 protein quizalofop-ethyl analog results in increased expression of ACOX1 mRNA PPARA protein affects the reaction [quizalofop-ethyl analog results in increased activity of ACOX1 protein]; PPARA protein affects the reaction [quizalofop-ethyl analog results in increased expression of ACOX1 mRNA]
CTD
PMID:29626562
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232
G
Cat
catalase
increases activity
EXP
quizalofop-ethyl analog results in increased activity of CAT protein
CTD
PMID:29626562
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ppara
peroxisome proliferator activated receptor alpha
increases response to substance multiple interactions
EXP
PPARA protein results in increased susceptibility to quizalofop-ethyl analog PPARA protein affects the reaction [quizalofop-ethyl analog results in increased activity of ACOX1 protein]; PPARA protein affects the reaction [quizalofop-ethyl analog results in increased expression of ACOX1 mRNA]
CTD
PMID:29626562
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
increases activity
ISO
quizalofop-ethyl results in increased activity of PPARG protein
CTD
PMID:31086981
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Xbp1
X-box binding protein 1
multiple interactions
ISO
rhosin inhibits the reaction [4-nitro-3-cresol results in increased expression of XBP1 mRNA]; rhosin inhibits the reaction [4-nitro-3-cresol results in increased expression of XBP1 protein]
CTD
PMID:35910793
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693
G
A2m
alpha-2-macroglobulin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of A2M mRNA
CTD
PMID:27935865
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:154,897,877...154,947,786
G
Abca8
ATP binding cassette subfamily A member 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ABCA8B mRNA
CTD
PMID:27935865
NCBI chr10:95,416,984...95,490,647
Ensembl chr10:94,917,520...94,990,988
G
Abhd14b
abhydrolase domain containing 14b
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ABHD14B mRNA]
CTD
PMID:29891994
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
G
Acod1
aconitate decarboxylase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ACOD1 mRNA
CTD
PMID:27935865
NCBI chr15:86,286,531...86,295,803
Ensembl chr15:79,871,827...79,880,529
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ACTA2 mRNA]
CTD
PMID:29891994
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
G
Actg2
actin gamma 2, smooth muscle
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ACTG2 mRNA
CTD
PMID:27935865
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:116,021,832...116,046,465
G
Adam8
ADAM metallopeptidase domain 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADAM8 mRNA
CTD
PMID:27935865
NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:194,770,060...194,788,801
G
Adcy5
adenylate cyclase 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCY5 mRNA
CTD
PMID:27935865
NCBI chr11:78,976,861...79,123,343
Ensembl chr11:65,471,612...65,618,974
G
Adcyap1r1
ADCYAP receptor type I
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCYAP1R1 mRNA
CTD
PMID:27935865
NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:84,593,892...84,642,700
G
Adgra2
adhesion G protein-coupled receptor A2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADGRA2 mRNA
CTD
PMID:27935865
NCBI chr16:71,635,814...71,674,275
Ensembl chr16:64,933,315...64,971,483
G
Adgrg3
adhesion G protein-coupled receptor G3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADGRG3 mRNA
CTD
PMID:27935865
NCBI chr19:9,972,425...10,001,118
Ensembl chr19:9,972,430...10,001,123
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADIPOQ mRNA
CTD
PMID:27935865
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adora1
adenosine A1 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADORA1 mRNA
CTD
PMID:27935865
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Agbl1
AGBL carboxypeptidase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AGBL1 mRNA
CTD
PMID:27935865
NCBI chr 1:139,453,667...140,360,473
Ensembl chr 1:130,043,970...130,951,638
G
Agtr2
angiotensin II receptor, type 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AGTR2 mRNA
CTD
PMID:27935865
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:112,120,228...112,124,057
G
Akr1d1
aldo-keto reductase family 1, member D1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AKR1D1 mRNA
CTD
PMID:27935865
NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:66,154,248...66,186,372
G
Ambp
alpha-1-microglobulin/bikunin precursor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AMBP mRNA
CTD
PMID:27935865
NCBI chr 5:81,583,621...81,593,938
Ensembl chr 5:76,568,094...76,578,331
G
Aoc3
amine oxidase, copper containing 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AOC3 mRNA
CTD
PMID:27935865
NCBI chr10:86,773,018...86,780,961
G
Apoc2
apolipoprotein C2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of APOC2 mRNA
CTD
PMID:27935865
NCBI chr 1:88,457,397...88,462,365
Ensembl chr 1:79,329,428...79,334,476
G
Arhgap36
Rho GTPase activating protein 36
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ARHGAP36 mRNA
CTD
PMID:27935865
NCBI chr X:128,780,148...128,787,169
Ensembl chr X:128,751,900...128,787,161
G
Arhgef19
Rho guanine nucleotide exchange factor 19
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARHGEF19 mRNA]
CTD
PMID:29891994
NCBI chr 5:153,536,038...153,554,203
Ensembl chr 5:153,536,013...153,554,203
G
Armcx6
armadillo repeat containing, X-linked 6
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARMCX6 mRNA]
CTD
PMID:29891994
NCBI chr X:97,929,032...97,932,031
Ensembl chr X:97,929,041...97,931,977
G
Asb10
ankyrin repeat and SOCS box-containing 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB10 mRNA
CTD
PMID:27935865
NCBI chr 4:10,630,318...10,644,270
Ensembl chr 4:10,630,448...10,639,060
G
Asb13
ankyrin repeat and SOCS box-containing 13
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ASB13 mRNA]
CTD
PMID:29891994
NCBI chr17:66,564,653...66,583,365
Ensembl chr17:66,562,434...66,583,337
G
Asb16
ankyrin repeat and SOCS box-containing 16
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB16 mRNA
CTD
PMID:27935865
NCBI chr10:87,225,976...87,233,078
Ensembl chr10:87,225,912...87,233,078
G
Ascl2
achaete-scute family bHLH transcription factor 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ASCL2 mRNA]
CTD
PMID:29891994
NCBI chr 1:207,578,447...207,665,126
Ensembl chr 1:198,148,999...198,151,406
G
Atp1a2
ATPase Na+/K+ transporting subunit alpha 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ATP1A2 mRNA
CTD
PMID:27935865
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:84,729,601...84,754,544
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ATP1A3 mRNA
CTD
PMID:27935865
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:80,572,796...80,601,918
G
Avpr1a
arginine vasopressin receptor 1A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AVPR1A mRNA
CTD
PMID:27935865
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:58,114,284...58,122,215
G
B4galnt2
beta-1,4-N-acetyl-galactosaminyl transferase 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of B4GALNT2 mRNA
CTD
PMID:27935865
NCBI chr10:81,298,338...81,324,738
Ensembl chr10:80,802,941...80,857,700
G
Bend4
BEN domain containing 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of BEND4 mRNA
CTD
PMID:27935865
NCBI chr14:40,753,048...40,788,686
Ensembl chr14:40,753,077...40,783,504
G
Bhlha15
basic helix-loop-helix family, member a15
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BHLHA15 mRNA
CTD
PMID:27935865
NCBI chr12:15,534,123...15,538,299
Ensembl chr12:10,420,467...10,424,713
G
Bpifa5
BPI fold containing family A, member 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of BPIFA5 mRNA
CTD
PMID:27935865
NCBI chr 3:163,106,258...163,113,039
Ensembl chr 3:142,646,103...142,652,883
G
Bpifb1
BPI fold containing family B, member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BPIFB1 mRNA
CTD
PMID:27935865
NCBI chr 3:163,133,151...163,166,420
Ensembl chr 3:142,672,995...142,706,256
G
Bricd5
BRICHOS domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BRICD5 mRNA
CTD
PMID:27935865
NCBI chr10:14,003,276...14,004,809
Ensembl chr10:13,498,381...13,500,259
G
Btn1a1
butyrophilin, subfamily 1, member A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BTN1A1 mRNA
CTD
PMID:27935865
NCBI chr17:41,653,499...41,664,246
Ensembl chr17:41,654,249...41,664,272
G
C1qtnf2
C1q and TNF related 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of C1QTNF2 mRNA
CTD
PMID:27935865
NCBI chr10:27,941,948...27,958,926
Ensembl chr10:27,941,948...27,959,185
G
C1qtnf7
C1q and TNF related 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of C1QTNF7 mRNA
CTD
PMID:27935865
NCBI chr14:67,467,888...67,580,477
Ensembl chr14:67,468,014...67,580,410
G
C5ar1
complement C5a receptor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR1 mRNA
CTD
PMID:27935865
NCBI chr 1:86,077,309...86,088,001
G
C5ar2
complement C5a receptor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR2 mRNA
CTD
PMID:27935865
NCBI chr 1:86,058,557...86,073,583
Ensembl chr 1:76,930,383...76,959,517
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CAMK2N1 mRNA]
CTD
PMID:29891994
NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:150,673,507...150,676,600
G
Car3
carbonic anhydrase 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CAR3 mRNA
CTD
PMID:27935865
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280
G
Card10
caspase recruitment domain family, member 10
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CARD10 mRNA]
CTD
PMID:29891994
NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:110,330,408...110,359,224
G
Cbx4
chromobox 4
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CBX4 mRNA]
CTD
PMID:29891994
NCBI chr10:104,835,685...104,841,727
Ensembl chr10:104,336,876...104,356,706
G
Ccdc42
coiled-coil domain containing 42
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCDC42 mRNA
CTD
PMID:27935865
NCBI chr10:53,289,956...53,300,135
Ensembl chr10:53,289,956...53,300,135
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL2 mRNA
CTD
PMID:27935865
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL3 mRNA
CTD
PMID:27935865
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl7
C-C motif chemokine ligand 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL7 mRNA
CTD
PMID:27935865
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,016,446...67,018,303
G
Ccna1
cyclin A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCNA1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CCNA1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:139,201,074...139,243,157
G
Ccno
cyclin O
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCNO mRNA
CTD
PMID:27935865
NCBI chr 2:46,364,074...46,367,113
Ensembl chr 2:44,626,369...44,633,914
G
Cd177
CD177 molecule
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CD177 mRNA
CTD
PMID:27935865
NCBI chr 1:89,467,926...89,488,490
Ensembl chr 1:80,340,034...80,360,621
G
Cd5l
Cd5 molecule-like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CD5L mRNA
CTD
PMID:27935865
NCBI chr 2:175,088,915...175,099,928
Ensembl chr 2:172,790,934...172,829,753
G
Cdc20b
cell division cycle 20B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CDC20B mRNA
CTD
PMID:27935865
NCBI chr 2:44,688,349...44,738,056
G
Cdh26
cadherin 26
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CDH26 mRNA
CTD
PMID:27935865
NCBI chr 3:185,898,185...185,950,892
Ensembl chr 3:165,520,439...165,572,149
G
Cdhr1
cadherin-related family member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CDHR1 mRNA
CTD
PMID:27935865
NCBI chr16:12,863,696...12,883,579
Ensembl chr16:12,843,437...12,863,396
G
Celsr3
cadherin, EGF LAG seven-pass G-type receptor 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CELSR3 mRNA
CTD
PMID:27935865
NCBI chr 8:118,409,136...118,438,593
Ensembl chr 8:109,530,641...109,558,354
G
Cfd
complement factor D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CFD mRNA
CTD
PMID:27935865
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:9,813,150...9,815,053
G
Chi3l1
chitinase 3 like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CHI3L1 mRNA
CTD
PMID:27935865
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:45,641,802...45,649,787
G
Chodl
chondrolectin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHODL mRNA
CTD
PMID:27935865
NCBI chr11:17,654,137...17,676,450
Ensembl chr11:17,654,206...17,676,441
G
Chrdl1
chordin-like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRDL1 mRNA
CTD
PMID:27935865
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
G
Chrm2
cholinergic receptor, muscarinic 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRM2 mRNA
CTD
PMID:27935865
NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,014,144...65,149,103
G
Chst6
carbohydrate sulfotransferase 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CHST5 mRNA
CTD
PMID:27935865
NCBI chr19:56,769,991...56,790,276
Ensembl chr19:39,860,501...39,881,064
G
Cidec
cell death-inducing DFFA-like effector c
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CIDEC mRNA
CTD
PMID:27935865
NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:146,569,289...146,582,173
G
Ckmt2
creatine kinase, mitochondrial 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CKMT2 mRNA
CTD
PMID:27935865
NCBI chr 2:24,815,008...24,845,511
Ensembl chr 2:23,079,918...23,110,430
G
Clec4d
C-type lectin domain family 4, member D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4D mRNA
CTD
PMID:27935865
NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848
G
Clec4e
C-type lectin domain family 4, member E
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4E mRNA
CTD
PMID:27935865
NCBI chr 4:158,292,624...158,298,607
Ensembl chr 4:156,607,614...156,612,767
G
Cnn1
calponin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNN1 mRNA
CTD
PMID:27935865
NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:20,632,338...20,641,098
G
Cntfr
ciliary neurotrophic factor receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNTFR mRNA
CTD
PMID:27935865
NCBI chr 5:61,619,326...61,657,359
Ensembl chr 5:56,823,965...56,841,392
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of COLQ mRNA
CTD
PMID:27935865
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
G
Cox7a1
cytochrome c oxidase subunit 7A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of COX7A1 mRNA
CTD
PMID:27935865
NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:85,441,871...85,445,151
G
Cplx1
complexin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CPLX1 mRNA
CTD
PMID:27935865
NCBI chr14:1,329,073...1,360,781
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CREB1 mRNA]
CTD
PMID:29891994
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Creb3l3
cAMP responsive element binding protein 3-like 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CREB3L3 mRNA
CTD
PMID:27935865
NCBI chr 7:9,273,320...9,281,755
Ensembl chr 7:8,622,614...8,631,048
G
Crisp3
cysteine-rich secretory protein 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CRISP3 mRNA
CTD
PMID:27935865
NCBI chr 9:20,432,051...20,472,663
Ensembl chr 9:20,450,908...20,472,658
G
Crispld1
cysteine-rich secretory protein LCCL domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CRISPLD1 mRNA
CTD
PMID:27935865
NCBI chr 5:1,267,347...1,314,926
Ensembl chr 5:1,274,647...1,314,926
G
Cryl1
crystallin, lambda 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CRYL1 mRNA]
CTD
PMID:29891994
NCBI chr15:35,542,628...35,661,563
Ensembl chr15:31,427,054...31,545,997
G
Csf3
colony stimulating factor 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CSF3 mRNA
CTD
PMID:27935865
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Csf3r
colony stimulating factor 3 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CSF3R mRNA
CTD
PMID:27935865
NCBI chr 5:143,583,126...143,604,382
Ensembl chr 5:138,301,506...138,317,881
G
Csrp1
cysteine and glycine-rich protein 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CSRP1 mRNA]
CTD
PMID:29891994
NCBI chr13:49,709,928...49,731,141
Ensembl chr13:47,167,789...47,179,384
G
Ctsc
cathepsin C
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CTSC mRNA]
CTD
PMID:29891994
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:142,028,392...142,060,387
G
Cxcl12
C-X-C motif chemokine ligand 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CXCL12 mRNA
CTD
PMID:27935865
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL2 mRNA
CTD
PMID:27935865
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL3 mRNA
CTD
PMID:27935865
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL5 mRNA
CTD
PMID:27935865
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,310,426...17,313,093
G
Cxcr2
C-X-C motif chemokine receptor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCR2 mRNA
CTD
PMID:27935865
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:75,729,115...75,739,425
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYP2E1 mRNA
CTD
PMID:27935865
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp4f18
cytochrome P450, family 4, subfamily f, polypeptide 18
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CYP4F18 mRNA
CTD
PMID:27935865
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
G
Cys1
cystin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYS1 mRNA
CTD
PMID:27935865
NCBI chr 6:47,029,440...47,046,671
Ensembl chr 6:41,300,836...41,318,071
G
Dcaf12l1
DDB1 and CUL4 associated factor 12-like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCAF12L1 mRNA
CTD
PMID:27935865
NCBI chr X:123,695,286...123,698,905
Ensembl chr X:123,695,286...123,698,905
G
Dchs1
dachsous cadherin-related 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCHS1 mRNA
CTD
PMID:27935865
NCBI chr 1:169,516,758...169,550,789
Ensembl chr 1:160,104,931...160,124,808
G
Degs2
delta(4)-desaturase, sphingolipid 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of DEGS2 mRNA
CTD
PMID:27935865
NCBI chr 6:133,360,449...133,377,677
Ensembl chr 6:127,596,071...127,613,293
G
Derl3
derlin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DERL3 mRNA
CTD
PMID:27935865
NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,763,543...12,767,027
G
Dhdh
dihydrodiol dehydrogenase
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of DHDH mRNA]
CTD
PMID:29891994
NCBI chr 1:105,088,108...105,102,560
Ensembl chr 1:95,953,092...95,965,197
G
Dmbt1
deleted in malignant brain tumors 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DMBT1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of DMBT1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 1:195,047,702...195,126,704
Ensembl chr 1:185,617,294...185,696,478
G
Dmrta1
DMRT-like family A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DMRTA1 mRNA
CTD
PMID:27935865
NCBI chr 5:109,531,704...109,538,244
Ensembl chr 5:104,415,893...104,422,433
G
Dpt
dermatopontin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DPT mRNA
CTD
PMID:27935865
NCBI chr13:79,656,341...79,684,759
Ensembl chr13:77,123,115...77,151,639
G
Drd1
dopamine receptor D1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DRD1 mRNA
CTD
PMID:27935865
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Edn3
endothelin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EDN3 mRNA
CTD
PMID:27935865
NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:163,562,520...163,585,093
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of EEF1A2 mRNA]
CTD
PMID:29891994
NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:168,195,357...168,275,071
G
Egf
epidermal growth factor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EGF mRNA
CTD
PMID:27935865
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Epha3
Eph receptor A3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA3 mRNA
CTD
PMID:27935865
NCBI chr11:14,585,041...14,920,721
Ensembl chr11:1,140,985...1,473,900
G
Epha5
EPH receptor A5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA5 mRNA
CTD
PMID:27935865
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
G
Epyc
epiphycan
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPYC mRNA
CTD
PMID:27935865
NCBI chr 7:34,323,332...34,360,845
Ensembl chr 7:32,436,620...32,474,135
G
F2rl1
F2R like trypsin receptor 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F2RL1 mRNA]
CTD
PMID:29891994
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:26,772,278...26,785,226
G
F2rl3
F2R like thrombin or trypsin receptor 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of F2RL3 mRNA
CTD
PMID:27935865
NCBI chr16:17,151,516...17,153,509
Ensembl chr16:17,117,441...17,119,472
G
F3
coagulation factor III, tissue factor
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F3 mRNA]
CTD
PMID:29891994
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
Fam13c
family with sequence similarity 13, member C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FAM13C mRNA
CTD
PMID:27935865
NCBI chr20:18,064,706...18,186,888
Ensembl chr20:18,065,628...18,187,592
G
Fam240b
family with sequence similarity 240 member B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FAM240B mRNA
CTD
PMID:27935865
NCBI chr17:647,269...663,209
Ensembl chr17:657,303...663,206
G
Fat2
FAT atypical cadherin 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FAT2 mRNA]
CTD
PMID:29891994
NCBI chr10:39,864,765...39,957,027
Ensembl chr10:39,364,073...39,456,216
G
Fbln7
fibulin 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FBLN7 mRNA
CTD
PMID:27935865
NCBI chr 3:116,111,581...116,145,839
Ensembl chr 3:116,111,677...116,147,983
G
Fbxo40
F-box protein 40
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FBXO40 mRNA
CTD
PMID:27935865
NCBI chr11:63,794,452...63,812,697
Ensembl chr11:63,794,624...63,812,697
G
Fcrl2
Fc receptor-like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FCRL2 mRNA
CTD
PMID:27935865
NCBI chr 2:174,992,226...175,005,177
Ensembl chr 2:172,694,308...172,707,051
G
Fhod3
formin homology 2 domain containing 3
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FHOD3 mRNA]
CTD
PMID:29891994
NCBI chr18:16,267,830...16,700,508
Ensembl chr18:15,993,324...16,425,796
G
Foxn4
forkhead box N4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FOXN4 mRNA
CTD
PMID:27935865
NCBI chr12:47,997,308...48,020,526
Ensembl chr12:42,340,323...42,359,921
G
Fpr2
formyl peptide receptor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of FPR2 mRNA
CTD
PMID:27935865
NCBI chr 1:67,449,637...67,458,272
Ensembl chr 1:58,776,752...58,786,019
G
Frem1
Fras1 related extracellular matrix 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FREM1 mRNA
CTD
PMID:27935865
NCBI chr 5:97,321,266...97,469,523
Ensembl chr 5:97,322,538...97,469,543
G
Frmpd4
FERM and PDZ domain containing 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FRMPD4 mRNA
CTD
PMID:27935865
NCBI chr X:25,853,849...26,814,642
Ensembl chr X:25,853,934...26,814,637
G
Frzb
frizzled-related protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FRZB mRNA
CTD
PMID:27935865
NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:65,332,277...65,365,208
G
Gabra4
gamma-aminobutyric acid type A receptor subunit alpha 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GABRA4 mRNA
CTD
PMID:27935865
NCBI chr14:36,944,747...37,021,652
Ensembl chr14:36,590,782...36,665,844
G
Gal3st2
galactose-3-O-sulfotransferase 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of GAL3ST2 mRNA
CTD
PMID:27935865
NCBI chr 9:101,823,815...101,836,507
Ensembl chr 9:94,376,174...94,389,174
G
Gask1a
golgi associated kinase 1A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GASK1A mRNA
CTD
PMID:27935865
NCBI chr 8:121,610,779...121,643,742
Ensembl chr 8:121,610,787...121,642,942
G
Gcnt4
glucosaminyl (N-acetyl) transferase 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of GCNT4 mRNA
CTD
PMID:27935865
NCBI chr 2:29,987,944...30,017,708
Ensembl chr 2:28,252,860...28,283,082
G
Gdf10
growth differentiation factor 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GDF10 mRNA
CTD
PMID:27935865
NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343
G
Gfra3
GDNF family receptor alpha 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GFRA3 mRNA
CTD
PMID:27935865
NCBI chr18:26,297,828...26,326,105
Ensembl chr18:26,297,829...26,326,105
G
Gja3
gap junction protein, alpha 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GJA3 mRNA
CTD
PMID:27935865
NCBI chr15:35,296,946...35,322,405
Ensembl chr15:31,181,369...31,206,810
G
Gprasp2
G protein-coupled receptor associated sorting protein 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GPRASP2 mRNA
CTD
PMID:27935865
NCBI chr X:103,609,304...103,615,450
Ensembl chr X:98,817,593...98,824,402
G
Gstk1
glutathione S-transferase kappa 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of GSTK1 mRNA]
CTD
PMID:29891994
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:71,118,896...71,123,292
G
Gstz1
glutathione S-transferase zeta 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of GSTZ1 mRNA]
CTD
PMID:29891994
NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:106,794,074...106,805,284
G
Hes1
hes family bHLH transcription factor 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HES1 mRNA]
CTD
PMID:29891994
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:70,705,764...70,708,192
G
Hhip
Hedgehog-interacting protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of HHIP mRNA
CTD
PMID:27935865
NCBI chr19:44,768,038...44,856,878
Ensembl chr19:27,863,213...27,952,528
G
Hsd17b8
hydroxysteroid (17-beta) dehydrogenase 8
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HSD17B8 mRNA]
CTD
PMID:29891994
NCBI chr20:4,828,571...4,830,635
Ensembl chr20:4,822,026...4,828,742
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of HTR2B mRNA
CTD
PMID:27935865
NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:86,742,102...86,755,108
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IDH2 mRNA]
CTD
PMID:29891994
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Ido1
indoleamine 2,3-dioxygenase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of IDO1 mRNA
CTD
PMID:27935865
NCBI chr16:74,133,259...74,145,328
Ensembl chr16:67,430,578...67,442,730
G
Ifi27l2a
interferon, alpha-inducible protein 27 like 2A
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IFI27L2 mRNA]
CTD
PMID:29891994
NCBI chr 6:128,363,658...128,365,144
Ensembl chr 6:122,598,872...122,600,360
G
Il19
interleukin 19
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL19 mRNA
CTD
PMID:27935865
NCBI chr13:44,949,989...44,958,714
Ensembl chr13:42,399,138...42,405,473
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL1B mRNA
CTD
PMID:27935865
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Inmt
indolethylamine N-methyltransferase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of INMT mRNA
CTD
PMID:27935865
NCBI chr 4:85,648,459...85,652,755
Ensembl chr 4:84,318,197...84,322,493
G
Irf7
interferon regulatory factor 7
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRF7 mRNA]
CTD
PMID:29891994
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832
G
Irs2
insulin receptor substrate 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRS2 mRNA]
CTD
PMID:29891994
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:78,485,045...78,512,482
G
Isg15
ISG15 ubiquitin-like modifier
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ISG15 mRNA]
CTD
PMID:29891994
NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:166,784,148...166,785,435
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ITPR1 mRNA]
CTD
PMID:29891994
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:141,187,418...141,510,491
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ITPR3 mRNA]
CTD
PMID:29891994
NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,136,441...5,202,337
G
Jchain
joining chain of multimeric IgA and IgM
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of JCHAIN mRNA
CTD
PMID:27935865
NCBI chr14:19,822,976...19,831,072
Ensembl chr14:19,538,952...19,546,298
G
Kank4
KN motif and ankyrin repeat domains 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KANK4 mRNA
CTD
PMID:27935865
NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555
G
Kbtbd12
kelch repeat and BTB domain containing 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KBTBD12 mRNA
CTD
PMID:27935865
NCBI chr 4:122,571,903...122,645,895
Ensembl chr 4:121,016,257...121,088,443
G
Kcna1
potassium voltage-gated channel subfamily A member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNA1 mRNA
CTD
PMID:27935865
NCBI chr 4:161,150,378...161,160,051
Ensembl chr 4:159,464,188...159,472,682
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNMA1 mRNA
CTD
PMID:27935865
NCBI chr15:351,065...1,057,117
Ensembl chr15:302,214...1,001,198
G
Klhl13
kelch-like family member 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL13 mRNA
CTD
PMID:27935865
NCBI chr X:113,942,309...114,107,299
Ensembl chr X:113,942,309...114,107,321
G
Klhl33
kelch-like family member 33
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL33 mRNA
CTD
PMID:27935865
NCBI chr15:24,105,923...24,114,445
Ensembl chr15:24,105,930...24,114,438
G
Klhl4
kelch-like family member 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL4 mRNA
CTD
PMID:27935865
NCBI chr X:83,626,047...83,916,328
Ensembl chr X:79,622,113...79,719,480
G
Klk6
kallikrein related-peptidase 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KLK6 mRNA
CTD
PMID:27935865
NCBI chr 1:103,415,411...103,422,682
Ensembl chr 1:94,280,340...94,286,121
G
Kng2
kininogen 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KNG2 mRNA
CTD
PMID:27935865
NCBI chr11:91,418,470...91,440,841
Ensembl chr11:77,909,612...78,002,971
G
Krt16
keratin 16
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT16 mRNA
CTD
PMID:27935865
NCBI chr10:85,669,276...85,672,211
Ensembl chr10:85,066,802...85,171,799
G
Krt84
keratin 84
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT84 mRNA
CTD
PMID:27935865
NCBI chr 7:132,649,064...132,656,885
Ensembl chr 7:132,649,061...132,656,874
G
Letmd1
LETM1 domain containing 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LETMD1 mRNA]
CTD
PMID:29891994
NCBI chr 7:133,461,920...133,476,592
Ensembl chr 7:131,584,259...131,597,796
G
Lin28a
lin-28 homolog A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LIN28A mRNA
CTD
PMID:27935865
NCBI chr 5:151,510,891...151,527,884
Ensembl chr 5:146,227,119...146,244,122
G
Lipf
lipase F, gastric type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LIPF mRNA
CTD
PMID:27935865
NCBI chr 1:240,906,706...240,925,053
Ensembl chr 1:231,493,498...231,511,845
G
Lipn
lipase, family member N
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LIPN mRNA
CTD
PMID:27935865
NCBI chr 1:240,998,154...241,016,658
Ensembl chr 1:231,584,956...231,603,468
G
Lman1l
lectin, mannose-binding, 1 like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LMAN1L mRNA
CTD
PMID:27935865
NCBI chr 8:66,906,684...66,925,512
Ensembl chr 8:58,010,839...58,023,681
G
Lmntd1
lamin tail domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LMNTD1 mRNA
CTD
PMID:27935865
NCBI chr 4:178,354,302...178,588,483
Ensembl chr 4:178,354,137...178,588,477
G
Lmo4
LIM domain only 4
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LMO4 mRNA]
CTD
PMID:29891994
NCBI chr 2:235,924,574...235,941,609
Ensembl chr 2:233,264,182...233,280,880
G
Lmod3
leiomodin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LMOD3 mRNA
CTD
PMID:27935865
NCBI chr 4:131,400,643...131,415,411
Ensembl chr 4:129,843,970...129,858,244
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LRG1 mRNA
CTD
PMID:27935865
NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:947,516...949,813
G
Lrrc3b
leucine rich repeat containing 3B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LRRC3B mRNA
CTD
PMID:27935865
NCBI chr15:9,973,580...10,050,891
Ensembl chr15:9,969,983...10,051,066
G
Lrrc4b
leucine rich repeat containing 4B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LRRC4B mRNA
CTD
PMID:27935865
NCBI chr 1:94,922,034...94,956,309
Ensembl chr 1:94,935,603...94,956,263
G
Mamstr
MEF2 activating motif and SAP domain containing transcriptional regulator
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MAMSTR mRNA
CTD
PMID:27935865
NCBI chr 1:105,246,172...105,252,759
Ensembl chr 1:96,110,343...96,115,744
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of MAP1LC3A mRNA]
CTD
PMID:29891994
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Mcidas
multiciliate differentiation and DNA synthesis associated cell cycle protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MCIDAS mRNA
CTD
PMID:27935865
NCBI chr 2:44,636,820...44,644,551
Ensembl chr 2:44,636,856...44,642,601
G
Mfap4
microfibril associated protein 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MFAP4 mRNA
CTD
PMID:27935865
NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,167,217...46,170,155
G
Mgam
maltase-glucoamylase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MGAM mRNA
CTD
PMID:27935865
NCBI chr 4:70,408,263...70,568,752
Ensembl chr 4:69,446,150...69,692,715
G
Mme
membrane metallo-endopeptidase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MME mRNA
CTD
PMID:27935865
NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:147,722,086...147,803,792
G
Mmp10
matrix metallopeptidase 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MMP10 mRNA
CTD
PMID:27935865
NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:4,689,840...4,697,748
G
Mmp8
matrix metallopeptidase 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MMP8 mRNA
CTD
PMID:27935865
NCBI chr 8:13,008,873...13,018,729
Ensembl chr 8:4,724,029...4,733,520
G
Mstn
myostatin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MSTN mRNA
CTD
PMID:27935865
NCBI chr 9:55,944,513...55,950,913
Ensembl chr 9:48,452,533...48,458,933
G
Msx3
msh homeobox 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MSX3 mRNA
CTD
PMID:27935865
NCBI chr 1:204,268,688...204,271,881
Ensembl chr 1:194,839,041...194,841,969
G
Musk
muscle associated receptor tyrosine kinase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MUSK mRNA
CTD
PMID:27935865
NCBI chr 5:77,853,560...77,967,653
Ensembl chr 5:73,058,121...73,171,932
G
Myadml2
myeloid-associated differentiation marker-like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYADML2 mRNA
CTD
PMID:27935865
NCBI chr10:105,922,557...105,927,867
Ensembl chr10:105,925,947...105,927,575
G
Myh13
myosin heavy chain 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYH13 mRNA
CTD
PMID:27935865
NCBI chr10:52,511,773...52,567,951
Ensembl chr10:52,009,425...52,068,951
G
Myoc
myocilin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOC mRNA
CTD
PMID:27935865
NCBI chr13:77,509,963...77,520,361
Ensembl chr13:74,976,730...74,987,127
G
Myocd
myocardin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOCD mRNA
CTD
PMID:27935865
NCBI chr10:50,332,356...50,426,819
Ensembl chr10:49,836,641...49,927,627
G
Myog
myogenin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOG mRNA
CTD
PMID:27935865
NCBI chr13:48,297,476...48,300,065
Ensembl chr13:45,745,436...45,748,039
G
Myoz3
myozenin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOZ3 mRNA
CTD
PMID:27935865
NCBI chr18:54,026,133...54,046,151
Ensembl chr18:54,026,152...54,102,126
G
Nags
N-acetylglutamate synthase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NAGS mRNA
CTD
PMID:27935865
NCBI chr10:87,098,330...87,102,465
Ensembl chr10:87,098,330...87,102,465
G
Nell2
neural EGFL like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NELL2 mRNA
CTD
PMID:27935865
NCBI chr 7:128,222,333...128,542,127
Ensembl chr 7:126,198,851...126,733,503
G
Nfe2
nuclear factor, erythroid 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NFE2 mRNA
CTD
PMID:27935865
NCBI chr 7:136,261,234...136,273,850
Ensembl chr 7:134,382,761...134,390,108
G
Nkx2-8
NK2 homeobox 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NKX2-9 mRNA
CTD
PMID:27935865
NCBI chr 6:79,821,342...79,823,045
Ensembl chr 6:74,086,274...74,087,977
G
Nkx3-1
NK3 homeobox 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NKX3-1 mRNA
CTD
PMID:27935865
NCBI chr15:50,883,661...50,886,253
Ensembl chr15:44,473,851...44,476,441
G
Nlrp12
NLR family, pyrin domain containing 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NLRP12 mRNA
CTD
PMID:27935865
NCBI chr 1:74,848,020...74,885,945
Ensembl chr 1:65,932,595...65,960,934
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NLRP3 mRNA
CTD
PMID:27935865
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
G
Npy
neuropeptide Y
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NPY mRNA
CTD
PMID:27935865
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Ntf3
neurotrophin 3
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of NTF3 mRNA]
CTD
PMID:29891994
NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:158,914,957...158,984,596
G
Olfml1
olfactomedin-like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of OLFML1 mRNA
CTD
PMID:27935865
NCBI chr 1:161,478,129...161,502,541
Ensembl chr 1:161,478,242...161,502,537
G
Opcml
opioid binding protein/cell adhesion molecule-like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of OPCML mRNA
CTD
PMID:27935865
NCBI chr 8:34,451,629...35,562,897
Ensembl chr 8:26,192,841...27,300,620
G
Otop2
otopetrin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of OTOP2 mRNA
CTD
PMID:27935865
NCBI chr10:100,564,727...100,574,298
Ensembl chr10:100,564,727...100,574,298
G
P2rx4
purinergic receptor P2X 4
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of P2RX4 mRNA]
CTD
PMID:29891994
NCBI chr12:39,505,438...39,523,349
Ensembl chr12:33,844,396...33,862,253
G
Pax1
paired box 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PAX1 mRNA
CTD
PMID:27935865
NCBI chr 3:155,244,961...155,254,836
Ensembl chr 3:134,789,182...134,801,636
G
Pax7
paired box 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PAX7 mRNA
CTD
PMID:27935865
NCBI chr 5:157,279,623...157,381,188
Ensembl chr 5:151,999,092...152,097,979
G
Pck1
phosphoenolpyruvate carboxykinase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PCK1 mRNA
CTD
PMID:27935865
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PCK2 mRNA]
CTD
PMID:29891994
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:29,027,894...29,037,283
G
Pde3a
phosphodiesterase 3A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PDE3A mRNA
CTD
PMID:27935865
NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:174,172,868...174,438,274
G
Perm1
PPARGC1 and ESRR induced regulator, muscle 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PERM1 mRNA
CTD
PMID:27935865
NCBI chr 5:166,800,030...166,805,323
Ensembl chr 5:166,800,030...166,805,323
G
Pgm5
phosphoglucomutase 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PGM5 mRNA
CTD
PMID:27935865
NCBI chr 1:231,752,052...231,939,812
Ensembl chr 1:222,325,643...222,513,437
G
Pgr
progesterone receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PGR mRNA
CTD
PMID:27935865
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
G
Phex
phosphate regulating endopeptidase X-linked
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PHEX mRNA
CTD
PMID:27935865
NCBI chr X:41,422,561...41,671,226
Ensembl chr X:37,610,760...37,854,469
G
Pira2
paired-Ig-like receptor A2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LILRA6 mRNA
CTD
PMID:27935865
NCBI chr 1:65,352,125...65,422,842
Ensembl chr 1:65,415,946...65,422,853
G
Pitx2
paired-like homeodomain 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PITX2 mRNA
CTD
PMID:27935865
NCBI chr 2:220,391,417...220,411,588
Ensembl chr 2:217,717,693...217,737,293
G
Pkhd1l1
PKHD1 like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PKHD1L1 mRNA
CTD
PMID:27935865
NCBI chr 7:77,505,063...77,679,994
Ensembl chr 7:75,620,484...75,795,335
G
Pkn1
protein kinase N1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PKN1 mRNA]
CTD
PMID:29891994
NCBI chr19:41,346,855...41,374,832
Ensembl chr19:24,442,122...24,470,107
G
Plcb4
phospholipase C, beta 4
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PLCB4 mRNA]
CTD
PMID:29891994
NCBI chr 3:143,405,721...143,775,129
Ensembl chr 3:122,953,196...123,322,392
G
Plin1
perilipin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PLIN1 mRNA
CTD
PMID:27935865
NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:133,664,892...133,676,828
G
Polr1h
RNA polymerase I subunit H
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of POLR1H mRNA]
CTD
PMID:29891994
NCBI chr20:1,600,170...1,604,088
Ensembl chr20:1,594,936...1,598,854
G
Ppbp
pro-platelet basic protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PPBP mRNA
CTD
PMID:27935865
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
G
Prap1
proline-rich acidic protein 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PRAP1 mRNA
CTD
PMID:27935865
NCBI chr 1:204,312,723...204,316,519
Ensembl chr 1:194,883,078...194,886,872
G
Prdm6
PR/SET domain 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRDM6 mRNA
CTD
PMID:27935865
NCBI chr18:49,102,290...49,206,763
Ensembl chr18:46,904,127...47,007,823
G
Prok2
prokineticin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PROK2 mRNA
CTD
PMID:27935865
NCBI chr 4:133,903,210...133,918,126
Ensembl chr 4:132,347,103...132,361,385
G
Prr32
proline rich 32
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRR32 mRNA
CTD
PMID:27935865
NCBI chr X:123,978,010...123,979,928
Ensembl chr X:123,977,985...123,979,942
G
Psors1c2
psoriasis susceptibility 1 candidate 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PSORS1C2 mRNA
CTD
PMID:27935865
NCBI chr20:3,206,886...3,208,307
Ensembl chr20:3,202,174...3,203,599
G
Ptgdr
prostaglandin D2 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PTGDR mRNA
CTD
PMID:27935865
NCBI chr15:19,790,499...19,797,873
Ensembl chr15:17,360,304...17,367,679
G
Ptgfr
prostaglandin F receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PTGFR mRNA
CTD
PMID:27935865
NCBI chr 2:240,731,185...240,766,674
Ensembl chr 2:240,733,375...240,765,650
G
Pwwp2b
PWWP domain containing 2B
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PWWP2B mRNA]
CTD
PMID:29891994
NCBI chr 1:194,040,395...194,059,979
Ensembl chr 1:194,041,341...194,059,958
G
Pxmp2
peroxisomal membrane protein 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PXMP2 mRNA]
CTD
PMID:29891994
NCBI chr12:52,053,951...52,064,283
Ensembl chr12:46,394,193...46,404,557
G
Pycr1
pyrroline-5-carboxylate reductase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PYCR1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PYCR1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr10:106,416,056...106,420,982
Ensembl chr10:105,917,680...105,922,549
G
Rab17
RAB17, member RAS oncogene family
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB17 mRNA]
CTD
PMID:29891994
NCBI chr 9:99,001,044...99,014,340
Ensembl chr 9:91,553,464...91,566,451
G
Rab2b
RAB2B, member RAS oncogene family
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB2B mRNA]
CTD
PMID:29891994
NCBI chr15:27,441,860...27,462,479
Ensembl chr15:24,968,803...24,989,113
G
Rap1gap
Rap1 GTPase-activating protein
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAP1GAP mRNA]
CTD
PMID:29891994
NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:149,892,019...149,939,253
G
Rasd2
RASD family, member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RASD2 mRNA
CTD
PMID:27935865
NCBI chr19:13,600,028...13,610,753
Ensembl chr19:13,594,291...13,605,016
G
Rcan2
regulator of calcineurin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RCAN2 mRNA
CTD
PMID:27935865
NCBI chr 9:24,456,861...24,674,234
Ensembl chr 9:16,959,480...17,174,856
G
Rdm1
RAD52 motif containing 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RDM1 mRNA]
CTD
PMID:29891994
NCBI chr10:86,562,871...86,573,034
Ensembl chr10:86,539,553...86,573,034
G
Retn
resistin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RETN mRNA
CTD
PMID:27935865
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620
G
Ripply1
ripply transcriptional repressor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RIPPLY1 mRNA
CTD
PMID:27935865
NCBI chr X:103,436,731...103,440,904
Ensembl chr X:103,436,729...103,443,349
G
Robo4
roundabout guidance receptor 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ROBO4 mRNA
CTD
PMID:27935865
NCBI chr 8:45,308,739...45,322,522
Ensembl chr 8:37,119,988...37,132,519
G
Rras
RAS related
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RRAS mRNA]
CTD
PMID:29891994
NCBI chr 1:104,637,061...104,640,841
Ensembl chr 1:95,500,566...95,504,357
G
Rtl3
retrotransposon Gag like 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RTL3 mRNA
CTD
PMID:27935865
NCBI chr X:71,947,343...71,951,008
Ensembl chr X:71,948,253...71,950,121
G
Rtl8a
retrotransposon Gag like 8A
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RTL8A mRNA]
CTD
PMID:29891994
NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RUNX1T1 mRNA
CTD
PMID:27935865
NCBI chr 5:31,984,946...32,136,878
Ensembl chr 5:27,187,551...27,335,592
G
S100a8
S100 calcium binding protein A8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of S100A8 mRNA
CTD
PMID:27935865
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of S100A9 mRNA
CTD
PMID:27935865
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:176,190,361...176,193,230
G
Samsn1
SAM domain, SH3 domain and nuclear localization signals, 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SAMSN1 mRNA
CTD
PMID:27935865
NCBI chr11:27,971,565...28,021,944
Ensembl chr11:14,483,893...14,534,900
G
Sbk2
SH3 domain binding kinase family, member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SBK2 mRNA
CTD
PMID:27935865
NCBI chr 1:77,902,926...77,910,758
Ensembl chr 1:68,874,152...68,881,916
G
Scg3
secretogranin III
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SCG3 mRNA
CTD
PMID:27935865
NCBI chr 8:85,280,253...85,322,484
Ensembl chr 8:76,399,777...76,442,015
G
Sell
selectin L
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SELL mRNA
CTD
PMID:27935865
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SELP mRNA
CTD
PMID:27935865
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Sfrp1
secreted frizzled-related protein 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SFRP1 mRNA]
CTD
PMID:29891994
NCBI chr16:75,278,325...75,316,736
Ensembl chr16:68,575,763...68,614,286
G
Sh2d5
SH2 domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SH2D5 mRNA
CTD
PMID:27935865
NCBI chr 5:150,469,738...150,480,615
Ensembl chr 5:150,467,728...150,479,955
G
Shisa8
shisa family member 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SHISA8 mRNA
CTD
PMID:27935865
NCBI chr 7:113,722,408...113,727,858
Ensembl chr 7:113,722,408...113,727,858
G
Shox2
SHOX homeobox 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SHOX2 mRNA
CTD
PMID:27935865
NCBI chr 2:153,524,324...153,537,571
Ensembl chr 2:151,217,552...151,227,143
G
Slc12a8
solute carrier family 12, member 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC12A8 mRNA
CTD
PMID:27935865
NCBI chr11:80,622,000...80,771,674
Ensembl chr11:67,116,877...67,266,834
G
Slc1a3
solute carrier family 1 member 3
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A3 mRNA]
CTD
PMID:29891994
NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:57,755,497...57,830,605
G
Slc1a5
solute carrier family 1 member 5
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A5 mRNA]
CTD
PMID:29891994
NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:77,456,694...77,470,952
G
Slc25a34
solute carrier family 25, member 34
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC25A34 mRNA
CTD
PMID:27935865
NCBI chr 5:159,215,120...159,219,892
G
Slc26a7
solute carrier family 26 member 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC26A7 mRNA
CTD
PMID:27935865
NCBI chr 5:32,681,653...32,819,110
Ensembl chr 5:27,887,042...28,021,658
G
Slc2a13
solute carrier family 2 member 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC2A13 mRNA
CTD
PMID:27935865
NCBI chr 7:124,278,881...124,606,146
Ensembl chr 7:122,399,330...122,726,605
G
Slc2a3
solute carrier family 2 member 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC2A3 mRNA
CTD
PMID:27935865
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472
G
Slc38a11
solute carrier family 38, member 11
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC38A11 mRNA
CTD
PMID:27935865
NCBI chr 3:49,987,119...50,033,615
Ensembl chr 3:49,987,124...50,033,615
G
Slc38a5
solute carrier family 38, member 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC38A5 mRNA
CTD
PMID:27935865
NCBI chr X:16,885,701...16,894,470
Ensembl chr X:14,213,729...14,222,498
G
Slc5a7
solute carrier family 5 member 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC5A7 mRNA
CTD
PMID:27935865
NCBI chr 9:7,922,693...7,953,509
Ensembl chr 9:7,595,444...7,626,258
G
Slc6a12
solute carrier family 6 member 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC6A12 mRNA
CTD
PMID:27935865
NCBI chr 4:156,257,518...156,275,870
Ensembl chr 4:154,585,500...154,603,750
G
Sln
sarcolipin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLN mRNA
CTD
PMID:27935865
NCBI chr 8:63,117,577...63,144,290
Ensembl chr 8:54,243,542...54,247,791
G
Snph
syntaphilin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SNPH mRNA
CTD
PMID:27935865
NCBI chr 3:140,098,540...140,139,342
Ensembl chr 3:140,099,708...140,139,453
G
Sorcs1
sortilin-related VPS10 domain containing receptor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SORCS1 mRNA
CTD
PMID:27935865
NCBI chr 1:249,080,662...249,594,520
Ensembl chr 1:249,081,355...249,594,507
G
Sox10
SRY-box transcription factor 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SOX10 mRNA
CTD
PMID:27935865
NCBI chr 7:112,605,721...112,615,097
Ensembl chr 7:110,725,274...110,735,544
G
Sox9
SRY-box transcription factor 9
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SOX9 mRNA]
CTD
PMID:29891994
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:97,806,485...97,811,994
G
Spats2l
spermatogenesis associated, serine-rich 2-like
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SPATS2L mRNA]
CTD
PMID:29891994
NCBI chr 9:59,319,949...59,493,864
Ensembl chr 9:59,320,276...59,493,967
G
Spon1
spondin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SPON1 mRNA
CTD
PMID:27935865
NCBI chr 1:177,363,526...177,662,689
Ensembl chr 1:167,928,972...168,228,226
G
Sprr1b
small proline-rich protein 1B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR1B mRNA
CTD
PMID:27935865
NCBI chr 2:180,704,457...180,706,355
Ensembl chr 2:178,009,130...178,009,567
G
Sprr2a
small proline rich protein 2A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2H mRNA
CTD
PMID:27935865
NCBI chr 2:180,511,568...180,511,840
Ensembl chr 2:177,815,964...177,816,236
G
Sprr2b
small proline rich protein 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2B mRNA
CTD
PMID:27935865
NCBI chr 2:177,852,824...177,853,096
Ensembl chr 2:177,852,824...177,853,096
G
Sprr2d
small proline-rich protein 2D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2D mRNA
CTD
PMID:27935865
NCBI chr 2:180,565,685...180,566,282
Ensembl chr 2:177,870,434...177,870,679
G
Sprr2f
small proline rich protein 2F
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2F mRNA
CTD
PMID:27935865
NCBI chr 2:177,989,974...177,990,204
Ensembl chr 2:177,989,974...177,990,204
G
Srgn
serglycin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SRGN mRNA
CTD
PMID:27935865
NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,442,813...30,457,406
G
Srpx
sushi-repeat-containing protein, X-linked
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SRPX mRNA
CTD
PMID:27935865
NCBI chr X:15,349,498...15,420,389
Ensembl chr X:12,566,645...12,747,882
G
St6galnac2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ST6GALNAC2 mRNA]
CTD
PMID:29891994
NCBI chr10:101,910,220...101,928,412
Ensembl chr10:101,909,971...101,915,008 Ensembl chr10:101,909,971...101,915,008
G
Stard10
StAR-related lipid transfer domain containing 10
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STARD10 mRNA]
CTD
PMID:29891994
NCBI chr 1:155,722,637...155,748,007
Ensembl chr 1:155,718,389...155,747,094
G
Stc2
stanniocalcin 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STC2 mRNA]
CTD
PMID:29891994
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,250,853...16,262,973
G
Stxbp5l
syntaxin binding protein 5L
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of STXBP5L mRNA
CTD
PMID:27935865
NCBI chr11:76,838,839...77,167,852
Ensembl chr11:63,334,667...63,657,014
G
Susd5
sushi domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SUSD5 mRNA
CTD
PMID:27935865
NCBI chr 8:113,996,771...114,036,133
Ensembl chr 8:113,997,362...114,035,861
G
Svopl
SVOP like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SVOPL mRNA
CTD
PMID:27935865
NCBI chr 4:67,663,652...67,725,691
Ensembl chr 4:66,698,177...66,758,978
G
Tagln
transgelin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TAGLN mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TAGLN mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:46,222,472...46,230,668
G
Tarm1
T cell-interacting, activating receptor on myeloid cells 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TARM1 mRNA
CTD
PMID:27935865
NCBI chr 1:74,582,103...74,600,203
Ensembl chr 1:65,671,902...65,679,626
G
Tbc1d16
TBC1 domain family, member 16
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TBC1D16 mRNA]
CTD
PMID:29891994
NCBI chr10:104,400,963...104,486,698
Ensembl chr10:104,402,398...104,486,670
G
Tbx15
T-box transcription factor 15
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TBX15 mRNA
CTD
PMID:27935865
NCBI chr 2:189,265,373...189,376,466
Ensembl chr 2:186,576,676...186,687,663
G
Tbxa2r
thromboxane A2 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TBXA2R mRNA
CTD
PMID:27935865
NCBI chr 7:9,034,077...9,041,489
Ensembl chr 7:8,383,378...8,388,176
G
Tdo2
tryptophan 2,3-dioxygenase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TDO2 mRNA
CTD
PMID:27935865
NCBI chr 2:169,567,656...169,585,586
Ensembl chr 2:167,269,579...167,287,511
G
Tff2
trefoil factor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TFF2 mRNA
CTD
PMID:27935865
NCBI chr20:9,217,110...9,220,979
Ensembl chr20:9,215,761...9,219,619
G
Tgm2
transglutaminase 2
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TGM2 mRNA]
CTD
PMID:29891994
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:146,772,687...146,801,981
G
Thrsp
thyroid hormone responsive
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of THRSP mRNA
CTD
PMID:27935865
NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:151,723,086...151,728,075
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TIMP1 mRNA
CTD
PMID:27935865
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Tmem132c
transmembrane protein 132C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM132C mRNA
CTD
PMID:27935865
NCBI chr12:29,115,213...29,437,900
Ensembl chr12:29,116,467...29,437,870
G
Tmem182
transmembrane protein 182
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM182 mRNA
CTD
PMID:27935865
NCBI chr 9:50,555,029...50,606,908
Ensembl chr 9:43,059,439...43,111,317
G
Tmem252
transmembrane protein 252
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TMEM252 mRNA
CTD
PMID:27935865
NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943
G
Tmem255a
transmembrane protein 255A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM255A mRNA
CTD
PMID:27935865
NCBI chr X:116,970,793...117,035,008
Ensembl chr X:116,970,695...117,035,008
G
Tmem30b
transmembrane protein 30B
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TMEM30B mRNA]
CTD
PMID:29891994
NCBI chr 6:97,987,471...97,990,546
Ensembl chr 6:92,249,790...92,254,842
G
Tnc
tenascin C
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNC mRNA]
CTD
PMID:29891994
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:77,375,851...77,460,624
G
Tnfrsf14
TNF receptor superfamily member 14
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNFRSF14 mRNA]
CTD
PMID:29891994
NCBI chr 5:170,768,413...170,776,749
Ensembl chr 5:165,484,262...165,493,703
G
Tnfsf14
TNF superfamily member 14
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFSF14 mRNA
CTD
PMID:27935865
NCBI chr 9:2,155,270...2,160,100
Ensembl chr 9:2,069,104...2,073,216
G
Tnfsf9
TNF superfamily member 9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFSF9 mRNA
CTD
PMID:27935865
NCBI chr 9:2,031,011...2,033,345
Ensembl chr 9:1,944,017...1,946,345
G
Tnni2
troponin I2, fast skeletal type
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNNI2 mRNA]
CTD
PMID:29891994
NCBI chr 1:206,882,358...207,027,034
Ensembl chr 1:197,594,813...197,597,560
G
Tnnt1
troponin T1, slow skeletal type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TNNT1 mRNA
CTD
PMID:27935865
NCBI chr 1:78,349,035...78,359,394
Ensembl chr 1:69,306,362...69,316,721
G
Tpd52l1
TPD52 like 1
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TPD52L1 mRNA]
CTD
PMID:29891994
NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:26,172,170...26,291,109
G
Trarg1
trafficking regulator of GLUT4 (SLC2A4) 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TRARG1 mRNA
CTD
PMID:27935865
NCBI chr10:62,019,281...62,039,666
Ensembl chr10:61,521,107...61,541,494
G
Trem1
triggering receptor expressed on myeloid cells 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TREM1 mRNA
CTD
PMID:27935865
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:12,763,819...12,779,203
G
Tril
TLR4 interactor with leucine-rich repeats
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TRIL mRNA
CTD
PMID:27935865
NCBI chr 4:84,252,781...84,257,626
Ensembl chr 4:82,922,328...82,927,172
G
Tst
thiosulfate sulfurtransferase
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TST mRNA]
CTD
PMID:29891994
NCBI chr 7:111,828,557...111,836,980
Ensembl chr 7:109,948,062...109,957,216
G
Tubb3
tubulin, beta 3 class III
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TUBB3 mRNA
CTD
PMID:27935865
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:51,457,184...51,466,243
G
Twist2
twist family bHLH transcription factor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TWIST2 mRNA
CTD
PMID:27935865
NCBI chr 9:99,822,242...99,866,722
Ensembl chr 9:92,374,574...92,419,222
G
Txlnb
taxilin beta
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TXLNB mRNA
CTD
PMID:27935865
NCBI chr 1:12,404,845...12,449,977
Ensembl chr 1:12,404,859...12,449,975
G
Upk3a
uroplakin 3A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of UPK3A mRNA
CTD
PMID:27935865
NCBI chr 7:116,128,981...116,139,950
Ensembl chr 7:116,134,874...116,139,948
G
Wfdc17
WAP four-disulfide core domain 17
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of WFDC17 mRNA
CTD
PMID:27935865
NCBI chr10:69,059,451...69,060,298
Ensembl chr10:68,561,954...68,562,801
G
Wnt2b
Wnt family member 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of WNT2B mRNA
CTD
PMID:27935865
NCBI chr 2:195,142,573...195,156,945
Ensembl chr 2:192,453,824...192,470,308
G
Zfp366
zinc finger protein 366
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ZFP366 mRNA
CTD
PMID:27935865
NCBI chr 2:32,312,712...32,376,996
Ensembl chr 2:30,578,715...30,642,182
G
Zfp524
zinc finger protein 524
multiple interactions
ISO
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ZNF524 mRNA]
CTD
PMID:29891994
NCBI chr 1:68,824,803...68,828,363
Ensembl chr 1:68,824,803...68,828,594
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
increases response to substance
ISO
ALDH5A1 gene mutant form results in increased susceptibility to XL765
CTD
PMID:29031482
NCBI chr17:40,560,373...40,586,711
Ensembl chr17:40,130,883...40,158,677
G
Mtor
mechanistic target of rapamycin kinase
decreases activity
ISO
XL765 results in decreased activity of MTOR protein
CTD
PMID:29031482
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all